French|born boss of AstraZeneca named highest|paid CEO in Britain

French-born boss of AstraZeneca named highest-paid CEO in Britain

Topping the compensation list was French-born Australian Pascal Soriot, who earned £16.85mn (€19.69mn) as the CEO of pharmaceutical giant ...

French-born boss of AstraZeneca named highest-paid CEO in Britain

French-born boss of AstraZeneca named highest-paid CEO in Britain · Median pay for the boss of a FTSE 100 firm rose to £4.19m (€4.90m), a 2.2% annual jump. · The ...

euronews on X: "French-born boss of AstraZeneca named highest ...

French-born boss of AstraZeneca named highest-paid CEO in Britain https://t.co/YIZCpSoQqB.

Pascal Soriot - Wikipedia

Sir Pascal Claude Roland Soriot (born 23 May 1959) is a French-born Australian businessman and chief executive of the British-Swedish multinational ...

AstraZeneca CEO 'massively underpaid' despite earning double ...

Soriot's pay packet in 2023 made him the highest-paid pharmaceutical boss in Europe, beating out the CEOs of companies like Novartis, Roche, and ...

Major investors say AstraZeneca boss is 'massively underpaid' on ...

Pascal Soriot is facing a revolt from shareholders after two advisory groups urged them to vote against the CEO's proposed £1.8 million ($2.3 million) raise.

CEO Today Top 50 - Pascal Soriot

Bio: Pascal Soriot, born on May 23, 1959 in France, is a French-born Australian businessman who currently serves as the CEO of AstraZeneca, a British-Swedish ...

AstraZeneca CEO set to earn £18.7 million after shareholder backing

The French-born CEO is already the highest earning boss on the UK's FTSE 100 exchange, taking home £16.9 million (€19.77) last year. Rajiv ...

AstraZeneca boss's £17m pay package under fire - The Guardian

“Pascal Soriot has consistently been one of the highest-paid CEOs in the FTSE 100, getting paid around 1,000 times more than a minimum wage ...

AstraZeneca's £18.7m CEO bounces back as pharma giant's sales ...

The top-paid boss on the FTSE 100, AstraZeneca's Pascal Soriot, bounced back today from the row over his salary, as the pharma giant ...

Britain's CEOs get record pay in 2023, research shows

The highest-paid British CEO was Pascal Soriot of drugmaker AstraZeneca, who earned 16.85 million pounds, the High Pay Centre said. Next was ...

'The man who saved the world': is AstraZeneca's boss worth his ...

There can't be many company bosses in Britain, or elsewhere in the world, “more deserving of a decent bonus this year than AstraZeneca's ...

AstraZeneca boss described as 'massively underpaid' - Business Plus

Soriot, 64, has been widely hailed for reviving the fortunes of one of Britain's biggest drug companies and providing millions with a life- ...

Soriot is 'massively underpaid' claims top AstraZeneca shareholder

One of the top earners worldwide in the drug sector is David Ricks, boss of Eli Lilly, who was paid £21million in 2023. ... executive pay, saying ...

Top-paid FTSE boss AstraZeneca's Pascal Soriot sees pay jump ...

Chief executive officer Mr Soriot was handed the sum after AstraZeneca's profits more than doubled in 2023 strong sales of its cancer treatments ...

The FTSE 100's highest paid CEO gets a pay rise - High Pay Centre

Astrazeneca's latest annual report showed that its CEO Pascal Soriot was paid £16.9 million in 2023 – a £1.6 million increase on his 2022 pay package.

Pascal Soriot :: Grabien - The Multimedia Marketplace - Grabien

Sir Pascal Claude Roland Soriot (born 23 May 1959) is a French-born Australian businessman and chief executive officer (CEO) of the British-Swedish ...

AstraZeneca hit by investor backlash over chief Pascal Soriot's ...

His remuneration was up from £16.9m in the prior year, which already made the French-born executive the highest paid boss on the FTSE 100.

AstraZeneca rocked by rebellion over boss Soriot's £19m pay

In a crunch vote yesterday, investors approved a new deal that will hand the chief executive Pascal Soriot up to £18.7million this year.

Leadership - Our Company - AstraZeneca

Pascal Soriot Executive Director and Chief Executive Officer. Member of the Board and CEO since October 2012. Read biography ...